Real‐world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis

oleh: Jun Ho Yi, Seok Jin Kim, Dok Hyun Yoon, Cheolwon Suh, Myung Hee Chang, Deok Hwan Yang, Jae‐Cheol Jo, Shin Young Hyun, Hyeon‐Seok Eom, Jeong‐Ok Lee, Ji Hyun Kwon, Sang Hoon Han, Seung‐Shin Lee, Jae‐Yong Kwak, Se Hyung Kim, Dae Sik Kim, Ji Hyun Lee, Sung Yong Oh, Hun Mo Ryoo, Hyo Jung Kim, Won Seog Kim